Location of Repository

Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial

By Efstratios Apostolakis, Nikolaos Panagopoulos, Efstratios N Koletsis, James Crockett, Helen Stamou-Kouki, Efrosini Sourgiadaki, Kriton Filos and Dimitrios Dougenis
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2287179
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2000). A: Blood use in lung resection for carcinoma:perioperative elective anemia does not compromise the early outcome. Eur J Cardiothorac Surg
    2. (1996). An anti-platelet-endothelial cell adhesion molecule1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane.
    3. (1995). Aprotinin and methylprednizolone equally blunt cardiopulmonary bypassinduced inflammation in humans. J Thorac Cardiovasc Surgery
    4. (2001). Aprotinin and the systemic inflammatory response following cardiopulmonary bypass. Ann Thorac Surg
    5. (1995). Aprotinin: a review of its pharmacology and therapeutic efficiency in reducing blood loss associated with cardiac surgery. Drugs
    6. (1999). Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs
    7. (2000). C: An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg
    8. (2004). Complications of pulmonary resection.
    9. (1999). Dalichau H: Chest re-exploration for complications after lung surgery. Thorac Cardiovasc Surg
    10. (2004). Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg
    11. (1998). Effects of aprotinin application on perioperative changes in hemostasis and fibrinolysis and its consequence for blood loss and transfusion requirement in lung surgery. Infusionther Transfusions Med
    12. (1999). L: Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Semin Thorac Cardiovasc Surg
    13. (2001). Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled randomized phase IV study.
    14. (1998). S: A retrospective study of the effects of small dose aprotinin on blood loss and transfusion needs during total hip arthroplasty.
    15. (1997). Sabate A: The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation. Hepatology
    16. (1987). Sapaford R: Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet
    17. (2001). Tasci O: Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study.
    18. (2004). The potential role of aprotinin in the peroperative management of malignant tumors.
    19. (1995). TJ: Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor. Blood
    20. (2001). Ultra-low dose Aprotinin decreases transfusion requirements and its cost effective in coronary operations. Ann Thorac Surg

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.